Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mu Sun

Showing results (161-170 of 338) with videos related to

Pageof 34
Sort By:
Cancer|June 22, 2010
Comparison of gefitinib versus erlotinib in patients with nonsmall cell lung cancer who failed previous chemotherapySeung Tae Kim, Jeeyun Lee, Jeong-Hoon Kim, et al.
Lung Cancer (Amsterdam, Netherlands)|July 6, 2010
Predictors of skeletal-related events in non-small cell lung cancer patients with bone metastasesJong-Mu Sun, Jin Seok Ahn, Soohyeon Lee, et al.
Nature Communications|September 21, 2019
DNA methylation loss promotes immune evasion of tumours with high mutation and copy number loadHyunchul Jung, Hong Sook Kim, Jeong Yeon Kim, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 5, 2018
Concurrent Genetic Alterations Predict the Progression to Target Therapy in EGFR-Mutated Advanced NSCLCYoujin Kim, Boram Lee, Joon Ho Shim, et al.
Lung Cancer (Amsterdam, Netherlands)|December 17, 2009
Unsuspected pulmonary emboli in lung cancer patients: the impact on survival and the significance of anticoagulation therapyJong-Mu Sun, Tae Sung Kim, Jeeyun Lee, et al.
Nature Communications|February 21, 2020
Predicting clinical benefit of immunotherapy by antigenic or functional mutations affecting tumour immunogenicityKwoneel Kim, Hong Sook Kim, Jeong Yeon Kim, et al.
Scientific Reports|March 21, 2020
Surgically Resected Esophageal Squamous Cell Carcinoma: Patient Survival and Clinicopathological Prognostic FactorsDong Young Jeong, Kyung Soo Lee, Joon Young Choi, et al.
Cancer Research and Treatment|January 22, 2011
Cisplatin-Based Combination Chemotherapy for Advanced Hepatocellular Carcinoma: A Single Center Experience before the Sorafenib EraNae Yu Kim, Jong Mu Sun, Yu-Jung Kim, et al.
Translational Lung Cancer Research|January 10, 2022
Molecular subtypes of small cell lung cancer transformed from adenocarcinoma after EGFR tyrosine kinase inhibitor treatmentSoohyun Hwang, Tae Hee Hong, Sehhoon Park, et al.
Clinical Lung Cancer|December 17, 2019
Benefit of Targeted DNA Sequencing in Advanced Non-Small-Cell Lung Cancer Patients Without EGFR and ALK Alterations on Conventional TestsSeonggyu Byeon, Boram Lee, Woong-Yang Park, et al.
Pageof 34

Showing results (161-170 of 338) with videos related to

Sort By:
Pageof 34
Cancer|June 22, 2010
Comparison of gefitinib versus erlotinib in patients with nonsmall cell lung cancer who failed previous chemotherapySeung Tae Kim, Jeeyun Lee, Jeong-Hoon Kim, et al.
Lung Cancer (Amsterdam, Netherlands)|July 6, 2010
Predictors of skeletal-related events in non-small cell lung cancer patients with bone metastasesJong-Mu Sun, Jin Seok Ahn, Soohyeon Lee, et al.
Nature Communications|September 21, 2019
DNA methylation loss promotes immune evasion of tumours with high mutation and copy number loadHyunchul Jung, Hong Sook Kim, Jeong Yeon Kim, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 5, 2018
Concurrent Genetic Alterations Predict the Progression to Target Therapy in EGFR-Mutated Advanced NSCLCYoujin Kim, Boram Lee, Joon Ho Shim, et al.
Lung Cancer (Amsterdam, Netherlands)|December 17, 2009
Unsuspected pulmonary emboli in lung cancer patients: the impact on survival and the significance of anticoagulation therapyJong-Mu Sun, Tae Sung Kim, Jeeyun Lee, et al.
Nature Communications|February 21, 2020
Predicting clinical benefit of immunotherapy by antigenic or functional mutations affecting tumour immunogenicityKwoneel Kim, Hong Sook Kim, Jeong Yeon Kim, et al.
Scientific Reports|March 21, 2020
Surgically Resected Esophageal Squamous Cell Carcinoma: Patient Survival and Clinicopathological Prognostic FactorsDong Young Jeong, Kyung Soo Lee, Joon Young Choi, et al.
Cancer Research and Treatment|January 22, 2011
Cisplatin-Based Combination Chemotherapy for Advanced Hepatocellular Carcinoma: A Single Center Experience before the Sorafenib EraNae Yu Kim, Jong Mu Sun, Yu-Jung Kim, et al.
Translational Lung Cancer Research|January 10, 2022
Molecular subtypes of small cell lung cancer transformed from adenocarcinoma after EGFR tyrosine kinase inhibitor treatmentSoohyun Hwang, Tae Hee Hong, Sehhoon Park, et al.
Clinical Lung Cancer|December 17, 2019
Benefit of Targeted DNA Sequencing in Advanced Non-Small-Cell Lung Cancer Patients Without EGFR and ALK Alterations on Conventional TestsSeonggyu Byeon, Boram Lee, Woong-Yang Park, et al.
Pageof 34